MCF Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

MCF Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-76	Closed	-$4K	–	522
2017 Q4	$4K	Hold	76	–	–	﹤0.01%	395
2017 Q3	$4K	Sell	76 -16	-17%	-$937	﹤0.01%	415
2017 Q2	$6K	Hold	92	–	–	﹤0.01%	397
2017 Q1	$5K	Buy	+92	New	+$4.53K	﹤0.01%	392

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

MCF Advisors's BIVV Position: Q1 2018 in Review

MCF Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 76 shares — an estimated $4K sold.

MCF Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $6K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

MCF Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
MCF Advisors sold 76 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $4K.
MCF Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
MCF Advisors's Bioverativ Inc. Common Stock position peaked at $6K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on MCF Advisors's 13F filing for Q1 2018, filed 10 May 2018.